Novo Nordisk

REBINYN

Manufacturer:

Novo Nordisk

Rebinyn HCPCS:

J7203

HCPCS Code Descriptor:

Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu

Category:

J Code

Rebinyn NDCs:

00169-7901-01, 00169-7905-01, 00169-7902-01, 00169-7903-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Rebinyn:

REBINYN is a Hematology drug manufactured by Novo Nordisk and administered via the Intravenous route of administration. The J Code: J7203 is aligned to the drug REBINYN.

ACCESS PRICING AND MORE BY REGISTERING

J7203 Added Date:

January 1, 2019

J7203 Effective Date:

January 1, 2019

J7203 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Rebinyn billing and coding information.
Rebinyn patient assistance information can be found through Novo Nordisk’s NovoCare at the URL: https://www.mynovosecure.com/resources.html
REBINYN prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for REBINYN. Please check back in a few weeks.